Steno Diabetes Center Aarhus
Steno Diabetes Center Aarhus is a public diabetes treatment, research, and education center operated by Region Midtjylland in Aarhus, Denmark, serving diabetes patients and healthcare professionals through clinical care, proprietary digital health platforms (SAMBLIK, INDBLIK), and multidisciplinary research programs.
- Company typePrivate
- Founded2018
- HeadquartersAarhus N, Denmark
- Headcount101–250
- GTM typeB2B and B2C
- OfferingServices
What Steno Diabetes Center Aarhus does
Steno Diabetes Center Aarhus (SDCA) is a public healthcare and research institution established in 2018 and operated by Region Midtjylland, with clinical operations housed in the Forum building at Aarhus Universitetshospital since September 2022. The center delivers specialized diabetes care to patients in Region Midtjylland across type 1, type 2, and early-onset type 2 diabetes, integrating treatment with clinical research and professional education. It is one of five regional Steno Diabetes Centers in Denmark, working alongside peer centers in Sjælland, Hovedstaden, and elsewhere.
The center's digital product portfolio centers on two proprietary platforms. SAMBLIK-diabetes is a cross-sector IT solution that aggregates patient data from hospitals, general practice, municipalities, the laboratory portal, and the Common Medicine Card, giving clinicians a single overview of treatment history, goals, and contacts; it has been co-financed by the Ministry of Health and deployed across Region Midtjylland, Region Sjælland, and Region Hovedstaden. INDBLIK is a remote monitoring tool that automatically retrieves blood sugar sensor data and surfaces alerts to clinicians. A 2026 addition is a digital decision-support tool for diabetes management during surgery, alongside a 2EARLY research program targeting early-onset type 2 diabetes. Professional education is delivered through a national 3-day insulin pump and glucose sensor course (3,000 DKK), the Diabetesforskerne podcast, and recurring seminars.
SDCA is a non-commercial public institution funded by the Danish regional healthcare system through Region Midtjylland, supplemented by research grants from Novo Nordisk Fonden (cumulative grants include 50M DKK for adipose tissue research, 25M DKK for INTEN-CT, 5M DKK for evening meal research), Kræftens Bekæmpelse (~5M DKK), Danmarks Frie Forskningsfond (1.5M DKK), and the Task force pool for chronic disease and inequality (3.9M DKK for SAMBLIK). Customer segments are individuals with diabetes in Region Midtjylland, healthcare professionals across hospitals, general practice, and municipalities, and academic research collaborators. With ~184 multidisciplinary staff, the center operates at the intersection of clinical care, applied research, and digital health innovation within the Danish public system.
Steno Diabetes Center Aarhus firmographics
Firmographics- Name
- Steno Diabetes Center Aarhus
- Legal name
- Steno Diabetes Center Aarhus
- Website
- https://stenoaarhus.dk
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Steno Diabetes Center Aarhus is a public diabetes treatment, research, and education center operated by Region Midtjylland in Aarhus, Denmark, serving diabetes patients and healthcare professionals through clinical care, proprietary digital health platforms (SAMBLIK, INDBLIK), and multidisciplinary research programs.
- Ownership category
- akta.pro rank
Steno Diabetes Center Aarhus industry classification
Industry- Product category
- Diabetes Healthcare Services
- NAICS
- Offices of Physicians (62111), Offices of Physicians (6211)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Diabetes (General) (HLAKADAA)
- akta.pro secondary industries
- Endocrinology & Diabetes Telemedicine Platforms (HLALAGAD), Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing (HLALAIAH)
Keywords
Where Steno Diabetes Center Aarhus is headquartered
LocationHeadquarters
- HQ city
- Aarhus N
- HQ country
- Denmark
- HQ region
- Europe
Offices1 record
Markets served
Steno Diabetes Center Aarhus business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Public Healthcare Services: As a public healthcare institution under Region Midtjylland, Steno Diabetes Center Aarhus is funded through the Danish public healthcare system. Services are provided as part of the regional healthcare infrastructure and are covered by public taxation.
- Research Grants and External Funding: The center receives research funding from Novo Nordisk Fonden (50 million DKK for fat tissue research, 5 million DKK for evening meal research, 25 million DKK for INTEN-CT study, plus other grants), Danmarks Frie Forskningsfond (1.5 million DKK for exercise research), Kræftens Bekæmpelse (approximately 5 million DKK for diabetes-cancer research), and other research foundations. Development of SAMBLIK was co-financed by the Ministry of Health.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | One time | Professional diabetes technology course for healthcare professionals |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels8 records
Steno Diabetes Center Aarhus product offering
Product offeringCore offering
Steno Diabetes Center Aarhus is a public healthcare and research institution that provides specialized diabetes treatment, clinical research, and professional education under Denmark's Region Midtjylland. It develops and operates digital health platforms (SAMBLIK-diabetes, INDBLIK) for cross-sector care coordination and remote patient monitoring, and delivers clinical consultations, training courses, and multidisciplinary research programs focused on type 1 and type 2 diabetes.
Product overview
Steno Diabetes Center Aarhus is a diabetes treatment, research, and education center offering a portfolio of digital health products and services. The core digital offerings include SAMBLIK-diabetes (a cross-sector data aggregation platform) and INDBLIK (a remote monitoring and need-based treatment tool). Additional services include professional training courses for diabetes technology, educational podcasts, and multidisciplinary research programs. The center functions as an integrated part of Aarhus University Hospital, combining clinical care with research, innovation, and knowledge sharing.
Differentiator
Problem solved
Functional benefit
Brands
- SAMBLIK: A digital IT solution that provides healthcare providers across sectors with the same overview of patients' disease history. Originally developed for type 2 diabetes patients and now being expanded to other disease areas.
- INDBLIK
Products and services
- SAMBLIK-diabetes A digital platform that aggregates patient data from multiple healthcare sectors (hospitals, general practice, municipalities) to provide healthcare professionals with a shared overview of treatment history, treatment goals, contacts with the healthcare system, and disease picture for persons with type 2 diabetes.
- INDBLIK A digital tool that automatically retrieves blood sugar data from patient sensors, presents it clearly to clinicians, and sends alerts for deviations or attention points in the patient's treatment course, supporting more differentiated and needs-based diabetes treatment.
- Digital Decision Tool for Diabetes and Surgery A digital decision-support tool for managing diabetes patients undergoing surgery that assists with calculations of medication doses and intervals for blood sugar measurements, providing more safety for staff and patients during surgical procedures.
- Insulin Pump and Glucose Sensor Training Course A national 3-day course for doctors, nurses, and dietitians involved in diabetes treatment with insulin pumps and glucose sensors. Healthcare professionals wear insulin pumps and glucose sensors during the course to better understand the patient experience.
- Diabetesforskerne (The Diabetes Researchers) Podcast
Quantifiable outcome
- Nearly 75% of people with type 2 diabetes in Denmark are well-treated
- +3 more outcomes
Companies that use Steno Diabetes Center Aarhus
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Steno Diabetes Center Aarhus technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Steno Diabetes Center Aarhus partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered minor and core.
- Danish Cancer Comprehensive Center (DCCC)minorCollaboration on SAMBLIK-Kræft concept development, which was mentioned in the Danish Cancer Plan V proposal.
- Minnesota UniversityminorInternational collaboration on the 5 million DKK evening meal research project studying effects on metabolism and inflammation.
- Nationalt Center for Overvægt (National Center for Obesity)minorCollaboration on conference 'Skal vi medicinere os ud af svær overvægt?' and training video development for exercise with obesity.
- Steno Diabetes Center SjællandcoreCollaboration on SAMBLIK-diabetes large-scale testing across multiple regions. Joint implementation of cross-sector digital health solution.
- Steno Diabetes Center HovedstadencoreCollaboration on SAMBLIK-diabetes large-scale testing across multiple regions. Joint implementation of cross-sector digital health solution.
- Aarhus UniversitetcoreAcademic partnership for research collaboration. Multiple researchers hold positions at both institutions. Joint research projects including the 50 million DKK Novo Nordisk Fonden grant for adipose tissue research.
- SundhedsdatastyrelsencoreSAMBLIK program oversight and governance. The Program Steering Group for 'Et Samlet Patientoverblik' serves as steering group for SAMBLIK implementation.
- Sundhedsministeriet (Ministry of Health)coreCo-financed the development of SAMBLIK-diabetes through grant funds. Active in supporting digital health innovation for chronic disease management.
Scale indicators9 records
Recent moves8 records
Expansion highlights7 records
Steno Diabetes Center Aarhus competitors and assessment
Company assessmentDirect peers
- Steno Diabetes Center Copenhagen (Steno Diabetes Center Hovedstaden): Sister Steno Diabetes Center serving Region Hovedstaden. Directly comparable model: public specialty/research center for diabetes with cross-sector digital tools, joint pilot partner with Steno Aarhus on SAMBLIK-diabetes.
- Steno Diabetes Center Nordjylland: Steno Diabetes Center in Region Nordjylland. Same mandate, funding model, and digital health innovation focus; part of the national Steno network that jointly competes and collaborates with Steno Aarhus.
- Steno Diabetes Center Sjælland: Regional Steno Diabetes Center in Region Sjælland. Same institutional model, joint SAMBLIK-diabetes rollout partner, and competing center for Danish diabetes research and clinical capacity.
- Joslin Diabetes Center: Harvard-affiliated US diabetes research and clinical center. International analogue combining specialist care, research, and provider education; provides benchmark for translational diabetes research output.
- Steno Diabetes Center Odense: Steno Diabetes Center serving Region Syddanmark. Same operating model combining clinical care, research, and education; competing for national research funding and talent.
Others
- Danish Diabetes and Endocrine Academy (DDEA): National training and research networking body for diabetes/endocrinology. Awards and networking infrastructure referenced in Steno Aarhus's research output; helps cultivate talent pool.
- Danmarks Nationale Diabetesregister (Danish Diabetes Association): National patient advocacy organization. Ecosystem participant that shapes political/public agendas for diabetes care in Denmark and influences the demand for Steno Aarhus's education and outreach.
Broad incumbents
- Aarhus Universitetshospital: Host hospital and broader clinical/research institution in which Steno Diabetes Center Aarhus is physically and operationally embedded. Provides shared infrastructure, multidisciplinary talent, and inpatient capacity.
- Novo Nordisk Foundation Center for Basic Metabolic Research: University of Copenhagen research center funded by Novo Nordisk Foundation. Comparable translational diabetes/metabolic research mandate; shares research funding pool with Steno Aarhus.
Regional players
- Diabetes UK: UK national diabetes charity and research funder. International peer in patient advocacy, research funding, and provider education; not a direct competitor but operates a similar model in a different geography.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Steno Diabetes Center Aarhus social profiles
Digital presenceSteno Diabetes Center Aarhus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Steno Diabetes Center Aarhus leadership team
Management profileNumber of profiles
Profiles4 records
Steno Diabetes Center Aarhus funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Steno Diabetes Center Aarhus M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Steno Diabetes Center Aarhus
What does Steno Diabetes Center Aarhus do?
Steno Diabetes Center Aarhus is a public healthcare and research institution that provides specialized diabetes treatment, clinical research, and professional education under Denmark's Region Midtjylland. It develops and operates digital health platforms (SAMBLIK-diabetes, INDBLIK) for cross-sector care coordination and remote patient monitoring, and delivers clinical consultations, training courses, and multidisciplinary research programs focused on type 1 and type 2 diabetes.
Is Steno Diabetes Center Aarhus a public or private company?
Steno Diabetes Center Aarhus is a private company. It is classified as state government owned and is currently operating.
When was Steno Diabetes Center Aarhus founded?
Steno Diabetes Center Aarhus was founded in 2018. It employs 101 to 250 people.
Where is Steno Diabetes Center Aarhus based?
Steno Diabetes Center Aarhus is headquartered in Aarhus N, Denmark, in the Europe region.
How does Steno Diabetes Center Aarhus make money?
Two revenue lines are on record. Public Healthcare Services are the primary driver. The others are research Grants and External Funding.
Who are Steno Diabetes Center Aarhus's main competitors?
Direct peers on record are Steno Diabetes Center Copenhagen (Steno Diabetes Center Hovedstaden), Steno Diabetes Center Nordjylland, Steno Diabetes Center Sjælland, Joslin Diabetes Center and Steno Diabetes Center Odense. Others are Danish Diabetes and Endocrine Academy (DDEA) and Danmarks Nationale Diabetesregister (Danish Diabetes Association). Broad incumbents are Aarhus Universitetshospital and Novo Nordisk Foundation Center for Basic Metabolic Research. Diabetes UK is listed as a regional player.
Does Steno Diabetes Center Aarhus have an API?
No public API is recorded for Steno Diabetes Center Aarhus.
What industry is Steno Diabetes Center Aarhus in?
Steno Diabetes Center Aarhus's product category is Diabetes Healthcare Services. Its primary akta.pro industry code is HLAKADAA, Diabetes (General), with a secondary code of HLALAGAD, Endocrinology & Diabetes Telemedicine Platforms. Its NAICS code is 62111 and its SIC code is 8011.